Literature DB >> 11443405

Intraarterial chemotherapy or chemoembolization for locally advanced and/or recurrent hepatic tumors: evaluation of the feeding artery with an interventional CT system.

T Hirai1, Y Korogi, K Ono, K Maruoka, K Harada, S Aridomi, M Takahashi.   

Abstract

PURPOSE: To evaluate the utility of an interventional CT system for intraarterial chemotherapy or chemoembolization for locally advanced and/or recurrent hepatic tumors.
METHODS: Thirty-eight patients with locally advanced or recurrent hepatic tumors underwent 73 intraarterial contrast-enhanced CT (IA-CECT) examinations immediately before chemotherapy or chemoembolization. The degree of tumor vascularity on angiography and enhancement on IA-CECT was classified into three grades: no, mild, or marked vascularity. The IA-CECT grades were compared with the angiographic grades.
RESULTS: Twenty-nine (69%) of 42 examinations that were interpreted as having no or mild vascularity on angiography were classified as marked enhancement on IA-CECT. Based on IA-CECT findings, the position of the catheter was changed in 14 (19%) of 73 CT examinations. The reasons for the reposition were as follows: weak or no enhancement of the tumor (n = 11) or strong enhancement of the gallbladder wall (n = 3). The treatment strategy was changed in three patients (8%). No major complications relating to the interventional procedures were observed.
CONCLUSIONS: IA-CECT is a reliable method when evaluating the perfusion of the tumor and adjacent normal tissues. The interventional CT system is useful for performing safe and effective intraarterial chemotherapy or chemoembolization in patients with locally advanced and/or recurrent hepatic tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443405     DOI: 10.1007/s002700000389

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  7 in total

1.  Preoperative embolization for meningeal tumors: evaluation of vascular supply with angio-CT.

Authors:  Toshinori Hirai; Yukunori Korogi; Ken Ono; Shozaburo Uemura; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

2.  A cone-beam volume CT using a 3D angiography system with a flat panel detector of direct conversion type: usefulness for superselective intra-arterial chemotherapy for head and neck tumors.

Authors:  S Kakeda; Y Korogi; Y Miyaguni; J Moriya; N Ohnari; N Oda; K Nishino; W Miyamoto
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

3.  [C-arm CT for planning and guidance of extrahepatic embolizations].

Authors:  F K Wacker; O A Meissner; B C Meyer
Journal:  Radiologe       Date:  2009-09       Impact factor: 0.635

4.  The value of combined soft-tissue and vessel visualisation before transarterial chemoembolisation of the liver using C-arm computed tomography.

Authors:  B C Meyer; M Witschel; B B Frericks; M Voges; W Hopfenmüller; K-J Wolf; F K Wacker
Journal:  Eur Radiol       Date:  2009-05-08       Impact factor: 5.315

5.  Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base.

Authors:  J Yokoyama; S Ohba; M Fujimaki; T Anzai; M Kojima; K Ikeda; M Suzuki; H Yoshimoto; K Inoue
Journal:  Br J Cancer       Date:  2014-09-25       Impact factor: 7.640

6.  Significant improvement in superselective intra-arterial chemotherapy for advanced paranasal sinus cancer by using indocyanine green fluorescence.

Authors:  Junkichi Yokoyama; Shinichi Ohba; Mitsuhisa Fujimaki; Masataka Kojima; Michimasa Suzuki; Katsuhisa Ikeda
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-08       Impact factor: 2.503

7.  5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

Authors:  Mingrong Cheng; Bing He; Tao Wan; Weiping Zhu; Jiang Han; Bingbing Zha; Houxiang Chen; Fengxiao Yang; Qing Li; Wei Wang; Hongzhi Xu; Tao Ye
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.